Combo Heart Pills Enter Trials in London

The cheap drugs could halve deaths from heart attack, stroke
By Matt Cantor,  Newser Staff
Posted Sep 29, 2008 8:16 AM CDT
Combo Heart Pills Enter Trials in London
It has been difficult to find funding for research into the cheap pills.   (Shutterstock)

Trials begin this week in London on a cheap "polypill" that could cut heart attack and stroke deaths in half worldwide, the Guardian reports. The pill combines four drugs—aspirin, a cholesterol-lowering statin, an ACE inhibitor, and thiazine to battle high blood pressure. The aim is to sell it—for about $1 a month—over the counter at pharmacies in the developing world, where cardiovascular disease is soaring.

Funding the long-envisioned polypill has been difficult because it offers little opportunity for drug-company profit. “We spent a few years trying to persuade a number of companies to do this, but got nowhere. A pill with established medicines that halved cardiovascular risk and could be available for £20 a year could be seen as a threat,” said a researcher. The so-called Red Heart pill has been manufactured by an Indian drug company for the two UK organizations backing the trials.
(More medicine stories.)

Get the news faster.
Tap to install our app.
X
Install the Newser News app
in two easy steps:
1. Tap in your navigation bar.
2. Tap to Add to Home Screen.

X